Medford, Mass.-based Seventh Sense Biosystems developed a device the size of a walnut to eliminate the fear, pain and inconvenience associated with drawing blood. TAP100 uses a ring of 30 ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the results of the second annual “Closing the Gap: CRC Screening Insights” ...
In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results